Relmada Therapeutics (RLMD) Income After Tax (2012 - 2026)
Relmada Therapeutics' Income After Tax was -$12.71 million in Q2 2026, compared with -$9.9 million a year earlier.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Income After Tax (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Relmada Therapeutics' Income After Tax was -$61.24 million through Jun 30, 2026; for FY2025, it came in at -$57.7 million.
- In earlier years, Income After Tax was -$80.36 million in FY2024, -$98.55 million in FY2023, -$161.25 million in FY2022 and -$125.7 million in FY2021.
- Quarterly Income After Tax has moved between -$45.51 million (Q2 2022) and -$9.9 million (Q2 2025) over five years.
- Per Business Quant data, RLMD's Income After Tax in the three quarters before Q2 2026 was -$18.5 million (Q1 2026), -$19.95 million (Q4 2025) and -$10.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Relmada Therapeutics | 455.48 Mn | -103.11 Mn | - | -12.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.71 Mn |
| Mar 31, 2026 | -18.50 Mn |
| Dec 31, 2025 | -19.95 Mn |
| Sep 30, 2025 | -10.08 Mn |
| Jun 30, 2025 | -9.90 Mn |
| Mar 31, 2025 | -17.78 Mn |
| Dec 31, 2024 | -18.42 Mn |
| Sep 30, 2024 | -22.15 Mn |
| Jun 30, 2024 | -17.86 Mn |
| Mar 31, 2024 | -21.93 Mn |
| Dec 31, 2023 | -25.57 Mn |
| Sep 30, 2023 | -21.37 Mn |
| Jun 30, 2023 | -24.66 Mn |
| Mar 31, 2023 | -26.95 Mn |
| Dec 31, 2022 | -37.59 Mn |
| Sep 30, 2022 | -37.91 Mn |
| Jun 30, 2022 | -45.12 Mn |
| Mar 31, 2022 | -37.97 Mn |
| Dec 31, 2021 | -34.02 Mn |
| Sep 30, 2021 | -42.36 Mn |
API Access
Relmada Therapeutics Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();